Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Akebia Therapeutics, Inc.

NASDAQ: AKBA · Life Sciences · 5 alerts · CIK 1517022

Share price
$0.4486Close, Nov 16
Market cap
$125M
Shares outstanding
277.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Akebia Therapeutics, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Akebia Therapeutics Nasdaq/NYSE Compliance Notice

Akebia Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 19, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least 10 consecutive business days. Akebia is evaluating options to cure the deficiency, including a potential reverse stock split.

Counterparty
Nasdaq
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.